Insider Transactions in Q1 2021 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Vincent A. Miller Director |
SELL
Open market or private sale
|
Direct |
3,200
-13.71%
|
$156,800
$49.0 P/Share
|
|
Mar 22
2021
|
Vincent A. Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+12.06%
|
$12,800
$4.73 P/Share
|
|
Mar 04
2021
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
11,200
+48.39%
|
-
|
|
Mar 04
2021
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,400
+48.35%
|
-
|
|
Mar 04
2021
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+5.62%
|
-
|
|
Mar 04
2021
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
48,000
+49.62%
|
-
|
|
Mar 04
2021
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+36.41%
|
-
|
|
Mar 01
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
5,000
-87.05%
|
$230,000
$46.0 P/Share
|
|
Mar 01
2021
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+46.54%
|
$5,000
$1.12 P/Share
|
|
Feb 24
2021
|
Neil Exter Director |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Feb 24
2021
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,500,000
-21.36%
|
-
|
|
Feb 08
2021
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
300,000
+50.0%
|
$13,500,000
$45.0 P/Share
|
|
Feb 05
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
15,000
-95.27%
|
$825,000
$55.0 P/Share
|
|
Feb 05
2021
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.79%
|
$15,000
$1.12 P/Share
|
|
Feb 05
2021
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
35,000
-75.76%
|
$1,925,000
$55.0 P/Share
|
|
Feb 05
2021
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+43.1%
|
$140,000
$4.73 P/Share
|
|
Feb 04
2021
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
5,000
-46.73%
|
$250,000
$50.94 P/Share
|
|
Feb 04
2021
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+42.34%
|
$20,000
$4.73 P/Share
|
|
Feb 02
2021
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
5,336
-74.69%
|
$240,120
$45.0 P/Share
|
|
Feb 02
2021
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
5,336
+42.76%
|
$5,336
$1.12 P/Share
|
|
Feb 02
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
5,000
-62.47%
|
$225,000
$45.76 P/Share
|
|
Feb 02
2021
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+46.54%
|
$5,000
$1.12 P/Share
|